Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Dopamine receptor for

Strange, P. G. Antipsychotic drugs importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol. Rev. 53 119-133, 2001. [Pg.224]

They act by a number of mechanisms, most notable of which is to block dopamine receptors. For example, aripiprazole has a high affinity for the serotonin type 2 (5-HT2) and dopamine types 2 (D2) and 3 (D3), moderate affinity for D4 and moderate affinity for 1- and 2-adrenergic and HI histaminergic receptors. It also has moderate affinity for the serotonin reuptake pump,... [Pg.151]

Strange PG Antipsychotic Drugs Importance of Dopamine Receptors for Mechanisms of Therapeutic Actions and Side Effects, Pharmacol. Rev, 53 119, 2001. [Pg.852]

Dopamine is the neurotransmitter that is most implicated in addictive behaviors. Drug addictions occur more readily in people who have inherited an abnormal dopamine receptor, for example. It is also a major transmitter in the reward pathway of the brain. Pleasurable activities such as eating and sex, release dopamine, so in terms of evolution, behaviors that promote human survival activate our built-in reward system. [Pg.125]

Application of the CCM to small sets (n < 6) of enzyme inhibitors revealed correlations between the inhibitory activity and the chirality measure of the inhibitors, calculated by Eq. (26) for the entire structure or for the substructure that interacts with the enzyme (pharmacophore) [41], This was done for arylammonium inhibitors of trypsin, Di-dopamine receptor inhibitors, and organophosphate inhibitors of trypsin, acetylcholine esterase, and butyrylcholine esterase. Because the CCM values are equal for opposite enantiomers, the method had to be applied separately to the two families of enantiomers (R- and S-enantiomers). [Pg.419]

Correlation between clinical effectiveness and receptor affinities, however, can be seen with other receptors in addition to the dopamine D2 receptor. These include other dopaminergic receptors, as well as noradrenergic and serotonergic receptors. For example, most antipsychotics also have high affinity for a -adrenoceptors and 5-HT2 receptors (225). Some antipsychotics have been shown to be selective for the adrenoceptor versus the a -adrenoceptor, for example, spiperone [749-02-0] (226) and risperidone (61) (221]... [Pg.236]

It has been suggested that high affinity for certain 5-HT receptors is a possible method for reducing extrapyramidal side effects observed with antipsychotics. LiabiUty for extrapyramidal side effects has been hypothesi2ed to be related to the ratio of the affinity between dopamine receptor... [Pg.237]

Psychostimulants. Figure 2 Dopamine molecules have two different possible targets. Both ways are initially increased by DAT inhibition caused by methylphenidate pre- and postsynaptic dopamine receptors. Stimulation of postsynaptic receptors results in inhibition of presynaptic action potential generation. On the other hand, presynaptic receptor stimulation leads to a transmission inhibition of action potentials. Therefore, both mechanisms are responsible for a decrease in vesicular depletion of dopamine into the synaptic cleft (adapted from [2]). [Pg.1042]

The GABAB-receptors, the muscarinic M2- and IVU-receptors for acetylcholine, the dopamine D2-, D3-and D4-receptors, the a2-adrenoceptors for noradrenaline, the 5-HTiA F-receptors for serotonin, and the opioid p-, 8- and K-receptors couple to G proteins of the Gi/o family and thereby lower [1] the cytoplasmic level of the second messenger cyclic AMP and [2] the open probability ofN- andP/Q-type Ca2+ channels (Table 1). The muscarinic Mr, M3- and M5-receptors for acetylcholine and the ai-adrenoceptors for noradrenaline couple to G proteins of the Gq/11 family and thereby increase the cytoplasmic levels of the second messengers inositol trisphosphate and diacylglycerol (Table 1). The dopamine Dr and D5-receptors and the (3-adrenoceptors for noradrenaline, finally, couple to Gs and thereby increase the cytoplasmic level of cyclic AMP. [Pg.1173]

The dopamine receptor agonists, such as pramipexole (Mirapex) and ropinirole (Requip), are used for die treatment of die signs and symptoms of Parkinson s disease... [Pg.269]

I younger adult receiving the antiparkinsonism drugs especially when taking the dopamine receptor agonists The nurse should assess the older adult for sgns of visual, auditory, or tactile hallucinations The incidence of halludnationsappears to increase with age. [Pg.271]

Explain what adverse reaction would be more likely to occur in the older adult prescribed a non-ergot dopamine receptor agonist drug. Describe how you would assess for this adverse reaction. [Pg.272]

Elderly patients prescribed one of the dopamine receptor agonists are monitored closely for which of the following adverse reactions ... [Pg.272]


See other pages where Dopamine receptor for is mentioned: [Pg.189]    [Pg.238]    [Pg.290]    [Pg.605]    [Pg.639]    [Pg.278]    [Pg.526]    [Pg.61]    [Pg.53]    [Pg.130]    [Pg.274]    [Pg.189]    [Pg.238]    [Pg.290]    [Pg.605]    [Pg.639]    [Pg.278]    [Pg.526]    [Pg.61]    [Pg.53]    [Pg.130]    [Pg.274]    [Pg.517]    [Pg.518]    [Pg.237]    [Pg.237]    [Pg.358]    [Pg.359]    [Pg.41]    [Pg.79]    [Pg.22]    [Pg.166]    [Pg.181]    [Pg.182]    [Pg.439]    [Pg.440]    [Pg.440]    [Pg.440]    [Pg.441]    [Pg.441]    [Pg.460]    [Pg.461]    [Pg.461]    [Pg.294]    [Pg.128]    [Pg.198]    [Pg.207]   
See also in sourсe #XX -- [ Pg.163 , Pg.169 ]

See also in sourсe #XX -- [ Pg.48 , Pg.49 , Pg.79 , Pg.79 ]




SEARCH



Competition Assays for Di and D2 Dopamine Receptors

Dopamine receptor

Receptors for

© 2024 chempedia.info